A roundup of all the week's news on Global University Venturing for our subscribers.
Seven Peaks culminates in $28m
US-based venture capital firm Seven Peaks Ventures closed its second fund yesterday with $28m in commitments from limited partners including OSU Foundation, the endowment manager of Oregon State University.
MIT toasts 32 spinouts
Massachusetts Institute of Technology (MIT)’s technology licensing office (TLO) spun out 32 companies and executed 124 licence agreements during the 2017-18 fiscal year.
IP Group sparks Flint’s interest
Douglas Flint has been appointed as chairman of IP Group, taking over from Mike Humphrey on November 1.
RSP Systems inspects $12.1m series B
RSP Systems, a spinout of University of Southern Denmark, has extended its series B round to $12.1m following a $4.5m extension backed by Trumpf Venture.
Strikingly slots in $10m series A-plus
US-based website creation tool developer Strikingly has received more than $10m in a series A-plus round that featured CAS Holding.
Allogene calls for $100m IPO
The immuno-oncology therapy developer’s investors include UC’s office of the chief investment officer, which contributed to a $300m round in January.
Alusid basks in $1.8m
University of Central Lancashire spinout Alusid has raised capital from Frontier IP to help fund a new factory for its building material made from recycled glass and porcelain.
SMPL unwraps $100,000
Organic snack producer SMPL has been backed by Zell Founders Fund, a VC vehicle run by University of Michigan students.
Twaice replenishes with $14m seed round
TUM-founded Twaice Technologies has won backing from UVC Partners to deliver battery management software targeting electric vehicles.
Oxbotica puts $18.5m in the tank
Autonomous vehicle software spinout Oxbotica has secured IP Group, Parkwalk Advisors and Axa XL as investors in its first publicly-disclosed funding round.
Immune-Onc books $33m series B
Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.
Exonate nurtures UBEF investment
The Parkwalk-managed University of Bristol Enterprise Fund has joined parent IP Group to become an investor in macular degeneration-focused spinout Exonate.
Madorra registers for $6m round
Stanford-StartX Fund is among medical device developer Madorra’s backers, along with Fogarty Institute of Innovation and OneVentures Healthcare.
NuNano magnifies investment
Bristol microscopy technology spinout NuNano has secured cash from the university’s Enterprise Fund for a second time.


